CELC
Price:
$12.4
Market Cap:
$460.41M
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative labora...[Read more]
Industry
Biotechnology
IPO Date
2017-09-20
Stock Exchange
NASDAQ
Ticker
CELC
According to Celcuity Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.77. This represents a change of -25.93% compared to the average of -6.44 of the last 4 quarters.
The mean historical PE Ratio of Celcuity Inc. over the last ten years is -18.47. The current -4.77 PE Ratio has changed 2.48% with respect to the historical average. Over the past ten years (40 quarters), CELC's PE Ratio was at its highest in in the June 2001 quarter at 0. The PE Ratio was at its lowest in in the March 2016 quarter at -1196.41.
Average
-18.47
Median
-15.50
Minimum
-39.89
Maximum
-5.22
Discovering the peaks and valleys of Celcuity Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 43.57%
Maximum Annual PE Ratio = -5.22
Minimum Annual Increase = -52.27%
Minimum Annual PE Ratio = -39.89
Year | PE Ratio | Change |
---|---|---|
2023 | -5.41 | 3.55% |
2022 | -5.22 | -9.54% |
2021 | -5.78 | -44.19% |
2020 | -10.35 | -33.23% |
2019 | -15.50 | -52.27% |
2018 | -32.47 | 43.57% |
2017 | -22.61 | -22.01% |
2016 | -29.00 | -27.31% |
The current PE Ratio of Celcuity Inc. (CELC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.47
5-year avg
-8.45
10-year avg
-18.47
Celcuity Inc.’s PE Ratio is less than Werewolf Therapeutics, Inc. (-1.10), greater than Edgewise Therapeutics, Inc. (-22.63), less than Decibel Therapeutics, Inc. (-1.95), less than C4 Therapeutics, Inc. (-2.68), less than Anebulo Pharmaceuticals, Inc. (-4.09), less than Adagene Inc. (-2.59), less than Acrivon Therapeutics, Inc. Common Stock (-3.15), less than AnaptysBio, Inc. (-2.44), less than Mineralys Therapeutics, Inc. (-3.92), less than Molecular Partners AG (-2.46), less than MediciNova, Inc. (-0.04), greater than Champions Oncology, Inc. (-184.36), greater than Cyteir Therapeutics, Inc. (-9.12), less than Ikena Oncology, Inc. (-1.35), less than Rezolute, Inc. (-4.47), less than Aerovate Therapeutics, Inc. (-0.87), less than AN2 Therapeutics, Inc. (-0.69),
Company | PE Ratio | Market cap |
---|---|---|
-1.10 | $69.96M | |
-22.63 | $2.84B | |
-1.95 | $123.37M | |
-2.68 | $286.59M | |
-4.09 | $32.42M | |
-2.59 | $83.23M | |
-3.15 | $198.03M | |
-2.44 | $425.09M | |
-3.92 | $600.21M | |
-2.46 | $200.54M | |
-0.04 | $103.98M | |
-184.36 | $112.07M | |
-9.12 | $108.71M | |
-1.35 | $80.59M | |
-4.47 | $257.27M | |
-0.87 | $73.92M | |
-0.69 | $41.83M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celcuity Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celcuity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Celcuity Inc.'s PE Ratio?
How is the PE Ratio calculated for Celcuity Inc. (CELC)?
What is the highest PE Ratio for Celcuity Inc. (CELC)?
What is the 3-year average PE Ratio for Celcuity Inc. (CELC)?
What is the 5-year average PE Ratio for Celcuity Inc. (CELC)?
How does the current PE Ratio for Celcuity Inc. (CELC) compare to its historical average?